Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1994-1-19
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0028-4793
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
13
|
pubmed:volume |
330
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
137-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8259170-Chronic Disease,
pubmed-meshheading:8259170-Hepatitis, Viral, Human,
pubmed-meshheading:8259170-Hepatitis B,
pubmed-meshheading:8259170-Hepatitis C,
pubmed-meshheading:8259170-Hepatitis D,
pubmed-meshheading:8259170-Humans,
pubmed-meshheading:8259170-Interferon-alpha,
pubmed-meshheading:8259170-Male
|
pubmed:year |
1994
|
pubmed:articleTitle |
Interferon therapy for chronic viral hepatitis.
|
pubmed:publicationType |
Editorial,
Comment
|